Clinical Trial Update: Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating injections of active allogeneic natural killer cells in patients with gliomas is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma
• High-grade Glioma

Drugs mentioned

• Active allogeneic natural killer cells (allogeneic natural killer cells)

Snippet

Sponsor: Marzieh Ebrahimi | Conditions: Glioma Glioblastoma Multiforme, High Grade Glioma (III or IV) | Phase 2 | Status: RECRUITING